800-331-6634

July, 2018

Testimony Tuesday

By editor
July 24, 2018
Upload: July 24, 2018

"I’d like to thank the staff for talking me through my surgery. They took my fear away by letting me know up front just what to expect. It was such a big help and relief! Dr. Hsu and the entire staff are amazing and dedicated to what they do. The patients at Mid Atlantic Retina...  read more


Genentech’s first implantable drug delivery system shows promising results in phase 2 wet AMD trial

By editor
July 10, 2018

Dr. Carl Regillo, a study investigator for Genentech’s first refillable eye implant, discusses the promising results in a phase 2 trial. The Port Delivery System is designed to deliver a new formulation of Lucentis' active ingredient, ranibizumab, continuously to wet age-related macular degeneration patients to avoid monthly eye injections. Read more about the new surgical implant here.